Lihit Lab Inc
Lihit Lab Inc provides industrial services and business support supplies, primarily generating revenue through the sale of goods and services in the industrial and commercial services sector.
Business. Lihit Lab Inc (7975.T) is a Japanese company headquartered in Japan that operates within the Business Support Supplies industry, focusing on the sale of industrial and commercial products. The firm is primarily listed on the Tokyo Stock Exchange under the ticker symbol 7975.T. Specific details regarding its operating segments and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a provider of business support supplies within the broader Industrials sector.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Lihit Lab Inc (7975.T) is a Japanese company headquartered in Japan that operates within the Business Support Supplies industry, focusing on the sale of industrial and commercial products. The firm is primarily listed on the Tokyo Stock Exchange under the ticker symbol 7975.T. Specific details regarding its operating segments and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a provider of business support supplies within the broader Industrials sector.
Lihit Lab Inc maintains a strong liquidity position, with a current ratio of 4.71, indicating the company can easily cover its short-term liabilities with its current assets. The company's cash and equivalents amount to ¥1,462,795,000, which provides a buffer against short-term obligations. The debt-to-equity ratio is 0.06, suggesting a conservative capital structure with minimal reliance on debt financing.
In terms of profitability, Lihit Lab Inc reports a return on equity (ROE) of 0.58% and a return on assets (ROA) of 0.45%. These figures are below the typical thresholds for high-performing industrial services firms, indicating that the company is not generating substantial returns relative to its equity and asset base. The operating income of ¥74,564,000 and net income of ¥59,833,000 suggest modest profitability, with a gross profit of ¥800,460,000 contributing to the bottom line.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to higher operational and market risks if demand in its primary market fluctuates.
Looking at the growth trajectory, Lihit Lab Inc's revenue for the latest period was ¥2,694,467,000, which is significantly higher than the analyst-estimated ¥9,124,180,000. This discrepancy suggests either a reporting period mismatch or a potential error in the analyst estimate. The company's growth outlook for the current fiscal year is not explicitly provided, but the modest net income and low ROE suggest limited growth potential in the near term.
The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and substantial cash reserves further support the low liquidity risk rating. However, the low ROE and ROA suggest that the company may need to explore new revenue streams or improve operational efficiency to enhance profitability.
Recent events, including the latest financial filing and analyst estimates, indicate that the company is maintaining a stable financial position. The absence of significant changes in the capital structure or new strategic initiatives suggests a conservative approach to business operations.
- Lihit Lab Inc maintains a strong liquidity position with a current ratio of 4.71 and substantial cash reserves.
- The company's profitability metrics, including ROE and ROA, are below industry benchmarks, indicating limited returns on equity and assets.
- Revenue is concentrated in a single business segment, with no material geographic diversification reported.
- The company's capital structure is conservative, with a low debt-to-equity ratio of 0.06.
- No immediate liquidity or dilution risks were detected, but the company may need to improve profitability to sustain long-term growth.
Bull / Bear case
Generated · model-assistedRevenue grew 1.2% CAGR over four years, demonstrating consistent top-line expansion despite volatile profitability trends.
The company maintains a low debt-to-equity ratio of 0.06, significantly below the cohort median of 0.22.
Gross profit increased to 3.1 billion JPY in FY2026, indicating strong underlying product margin performance.
Risk flags for dilution, liquidity, and credit are all rated low, suggesting a stable financial foundation.
Net income recovered to 411.6 million JPY in FY2025, showing resilience after two years of losses.
Net income CAGR was -28.9% over four years, reflecting a long-term trend of declining profitability.
In focus — financials by report
Revenue ¥2.33B, −1,5% YoY; Operating income −39,8% YoY.
- ▍Revenue ¥2.33B, −1,5% YoY
- ▍Operating income −39,8% YoY
- ▍Net income −78,5% YoY
- ▍Net margin 1.7%
Revenue ¥1.91B, −7,9% YoY; Operating income −13 146,0% YoY.
- ▍Revenue ¥1.91B, −7,9% YoY
- ▍Operating income −13 146,0% YoY
- ▍Net income −102,8% YoY
- ▍Net margin -0.3%
Revenue ¥2.08B, −0,3% YoY; Operating income −11,5% YoY.
- ▍Revenue ¥2.08B, −0,3% YoY
- ▍Operating income −11,5% YoY
- ▍Net income +145,4% YoY
- ▍Net margin 0.4%
Revenue ¥2.80B, +4,1% YoY; Operating income −80,9% YoY.
- ▍Revenue ¥2.80B, +4,1% YoY
- ▍Operating income −80,9% YoY
- ▍Net income −56,9% YoY
- ▍Net margin 0.9%
Revenue ¥2.37B; Operating income ¥114.1M.
- ▍Revenue ¥2.37B
- ▍Operating income ¥114.1M
- ▍Net margin 7.6%
Revenue ¥2.07B; Operating income ¥302.0k.
- ▍Revenue ¥2.07B
- ▍Operating income ¥302.0k
- ▍Net margin 9.0%
Revenue ¥2.08B; Operating income -¥11.0M.
- ▍Revenue ¥2.08B
- ▍Operating income -¥11.0M
- ▍Net margin -0.8%
Revenue ¥2.69B; Operating income ¥74.6M.
- ▍Revenue ¥2.69B
- ▍Operating income ¥74.6M
- ▍Net margin 2.2%
Revenue ¥9.12B, −1,0% YoY; Operating income −82,5% YoY.
- ▍Revenue ¥9.12B, −1,0% YoY
- ▍Operating income −82,5% YoY
- ▍Net income −83,7% YoY
- ▍Free cash flow −469,8% YoY
- ▍Net margin 0.7%
Revenue ¥9.22B, +4,7% YoY; Operating income +163,7% YoY.
- ▍Revenue ¥9.22B, +4,7% YoY
- ▍Operating income +163,7% YoY
- ▍Net income +539,1% YoY
- ▍Free cash flow +142,2% YoY
- ▍Net margin 4.5%
Revenue ¥8.80B, +3,4% YoY; Operating income −79,8% YoY.
- ▍Revenue ¥8.80B, +3,4% YoY
- ▍Operating income −79,8% YoY
- ▍Net income −283,9% YoY
- ▍Free cash flow −842,2% YoY
- ▍Net margin -1.1%
Revenue ¥8.51B, −2,1% YoY; Operating income −145,2% YoY.
- ▍Revenue ¥8.51B, −2,1% YoY
- ▍Operating income −145,2% YoY
- ▍Net income −109,3% YoY
- ▍Free cash flow −73,4% YoY
- ▍Net margin -0.3%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Return On Assetsnet_income / total_assets
- Lihit Lab Inc Market data — financials · 2026-05-27
- Lihit Lab Inc Market data — analyst estimates · 2026-05-27